A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus

Name: A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
Published: 2023
License: Public Domain

Bristol-Myers Squibb · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

autoimmune-diseases sle systemic-lupus-erythematosus

systemic lupus erythematosus, autoimmune diseases, immune system diseases, connective tissue diseases, immune-mediated diseases, active systemic lupus erythematosus, lupus, sle, deucravacitinib, tyk2, poetyk, poetyk sle

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 910098
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.